Bevnexxa 100mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Bevacizumab (100mg)
Overview Bevnexxa 100mg Injection
Oncaspar 100mg Injection, an anti-cancer agent, treats colorectal, non-small cell lung, renal, brain, ovarian, and cervical cancers. Its mechanism involves inhibiting tumor angiogenesis, thus hindering tumor growth. Highly effective, it's frequently a first-line treatment when combined with other oncology medications. Administered intravenously via infusion, either directly into a vein or through a subcutaneous port, dosage and treatment length are determined by your physician, who will monitor for infusion reactions like hypertension and respiratory distress. Continued use depends on disease control and manageable side effects, a decision made solely by your doctor. Regular blood pressure monitoring and urine protein checks may be recommended. Common side effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical notification of Oncaspar 100mg Injection use is vital due to its potential to impair wound healing and increase bleeding risk; report any unusual bleeding immediately. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor. Interaction with other medications is possible; inform your healthcare provider of all concurrent medications.
Uses of Bevnexxa 100mg Injection
Colorectal cancer, ovarian malignancy, cervical carcinoma, renal cell carcinoma, brain neoplasm, and non-small cell lung carcinoma.
Major Benefits of Bevnexxa 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bevnexxa 100mg Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Bevnexxa 100mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Bevnexxa 100mg Injection works:
Oncaspar 100mg injection is an anti-angiogenesis therapy. Its mechanism of action involves inhibiting vascular endothelial growth factor (VEGF), thereby preventing the development of new blood vessels that supply tumors with essential oxygen and nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Bevnexxa 100mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Bevnexxa 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Bevnexxa 100mg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Bevnexxa 100mg Injection may induce adverse reactions impacting driving capabilities. Reports indicate drowsiness and syncope as potential side effects of Bevnexxa 100mg Injection, thereby potentially compromising driving safety.
KidneySAFE IF PRESCRIBED
The use of Bevnexxa 100mg Injection in individuals with impaired kidney function is likely safe. Existing evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Bevnexxa 100mg Injection in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary for this population. However, physician consultation is recommended.
What if you forget to take Bevnexxa 100mg Injection :
Omit a scheduled dose of Bevnexxa 100mg Injection? Seek your physician's advice.
Facts to Know About Bevnexxa 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | VEGF inhibitor |
3,018 People bought this recently